Renal failure: Implications of chronic kidney disease in the management of the diabetic foot

Seminars in Vascular Surgery

Volumn 25, Issue 2, 2012, Pages 82-88

  Lewis, Shari ^a   Raj, Dominic ^a   Guzman, Nicolas J ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; NALFURAFINE; NALTREXONE; OXYGEN; SODIUM THIOSULFATE; ZINC;

AMPUTATION; ARTICLE; CALCINOSIS; CHRONIC KIDNEY DISEASE; DIABETIC FOOT; DIABETIC FOOT INFECTION; DIABETIC PATIENT; FOOT CARE; HEMODIALYSIS; HUMAN; HYPERBARIC OXYGEN; INFECTION; KIDNEY FAILURE; MORBIDITY; MORTALITY; NEPHROGENIC SYSTEMIC FIBROSIS; NEUROPATHY; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PRURITUS; PSYCHOSOCIAL DISORDER; RISK FACTOR; SKIN DISEASE; ULCER; UREMIA; UREMIC PRURITUS; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

AMPUTATION; COMBINED MODALITY THERAPY; COMORBIDITY; DIABETIC FOOT; DIABETIC NEPHROPATHIES; HUMANS; LIMB SALVAGE; RENAL INSUFFICIENCY; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; WOUND HEALING;

EID: 84864037283     PISSN: 08957967     EISSN: 15584518     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2012.04.007     Document Type: Article

References (45)

1. USRDS 2008, Annual Data Report: Atlas of End Stage Renal Disease in the United States 2008, US Renal Data System, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
2. Singh N., Armstrong D.G., Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA 2005, 293:217-228.
3. Gunter W., Muller N., Busch M., et al. Diabetic foot syndrome and renal function in type 1 and 2 diabetes mellitus show close association. Nephrol Dial Transplant 2009, 24:1896-1901.
4. O'Hare A., Johansen K. Lower extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 2001, 12:2838-2847.
5. Schomig M., Eberhard R., Eberhard S., et al. The diabetic foot in the dialyzed patient. J Am Soc Nephrol 2009, 11:1153-1159.
6. Margolis D.J., Hofstad O., Feldman H.I. Association between renal failure and foot ulcer or lower extremity amputation in patients with diabetes. Diabetes Care 2008, 31:1331-1336.
7. Colin J.F., Elliot P., Ellis H. The effect of uraemia upon wound healing: an experimental study. Br J Surg 1979, 66:93-797.
8. Ellis H. Wound healing. Ann R Coll Surg Engl 1977, 59:382-387.
9. O'Hare A.M. High prevalence of peripheral artery disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey. Circulation 2004, 109:320-323.
10. United States Renal Data System Annual Data Report, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Division of Kidney Urologic and Hematologic Diseases 2000, 339-348. USRDS.
11. Block G.A., Hulbert-Shearon T.E., Levin N.W., et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998, 31:607-617.
12. Goldsmith D.J.A., Covic A., Sambrook P.A., et al. Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. Nephron 1997, 77:37-43.
13. Ridker P.M., Cushman M., Stampfer M.J., et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998, 97:425-428.
14. Sethi D., Muller B.R., Brown E.A., et al. C-reactive protein in haemodialysis patients with dialysis arthropathy. Nephrol Dial Transplant 1988, 3:269-271.
15. Mustafa A., Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?. Kidney Int 2001, 59:407-414.
16. Dyck P.J., Johnson W.J., Lambert E.H., et al. Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc 1971, 46:400-431.
17. Fraser C.L., Arieff A.I. Nervous system complications in uremia. Ann Intern Med 1988, 109:143-153.
18. Deery G.H., Sangeorzan J.A. Saving the diabetic foot with special reference to the patient with chronic renal failure. Infect Dis Clin North Am 2001, 15:953-981.
19. Nielsen V.K. The peripheral nerve function in chronic renal failure. VI. The relationship between sensory and motor nerve conduction and kidney function, azotemia, age, sex, and clinical neuropathy. Acta Med Scand 1973, 194:455-462.
20. Kato S., Chimielewski M., Honda H., et al. Aspects of immune dysfunction in end stage renal disease. Clin J Am Soc Nephrol 2008, 3:1526-1533.
21. Cendoroglo M., Jaber B.L., Balakrishnan V.S., et al. Neutrophil apoptosis and dysfunction in uremia. J Am Soc Nephrol 1999, 10:93-100.
22. Cohen G., Haag-Weber M., Horl W.H. Immune dysfunction in uremia. Kidney Int Suppl 1997, 62:79-82.
23. Kurz P., Kohler H., Meuer S.C., et al. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney Int 1986, 29:1209-1214.
24. Yates C., May K., Hale T., et al. Wound chronicity, inpatient care, and chronic kidney disease predispose to MRSA infection in diabetic foot ulcers. Diabetes Care 2009, 32:1907-1909.
25. Pliquett R.U., Schwock J., Paschke R., et al. Calciphylaxis in chronic, non-dialysis-dependent renal disease. BMC Nephrol 2003, 4:8. 29.
26. Angelis M. Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery 1997, 122:1083-1090.
27. Nigwekar S.U. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol 2008, 3:1139-1143.
28. Yerram P., Saab G., Karuparthi P.R., et al. Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure-role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. Clin J Am Soc Nephrol 2007, 2:258-263.
29. Shellock F.G., Spinnazzi A. MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis. AJR Am J Roentgenol 2008, 191:1129-1139.
30. Deo A. Nephrogenic systemic fibrosis: epidemiology update. Curr Opin Nephrol Hypertens 2008, 17:315-319.
31. Rydahl C., Thomsen H.S., Marckmann P. High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent. Invest Radiol 2008, 3:747-751.
32. Idée J.M., Port M., Medina C., et al. Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review. Toxicology 2008, 27:77-88.
33. Kuypers D. Skin problems in chronic kidney disease. Nat Clin Pract Nephrol 2009, 5:157-170.
34. Pisoni R.L., Wikstrom B., Elder S.J., et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006, 21:3495-3505.
35. Cukor D., Cohen S.D., Peterson R.A., et al. Psychological aspects of chronic disease: ESRD as a paradigmatic illness. J Am Soc Nephrol 2007, 18:3042-3055.
36. Kimmel P.L. Psychological factors in dialysis patients. Kidney Int 2001, 59:1599-1613.
37. Pliakogiannis T., Bailey S., Cherukuri S., et al. Vascular complications of the lower extremities in diabetic patients on peritoneal dialysis. Clin Nephrol 2008, 69:361-367.
38. Mahajan S. Zinc in kidney disease. J Am Coll Nutr 1989, 8:296-304.
39. Lipscombe J., Jassal S.V., Bailey S., et al. Chiropody may prevent amputations in diabetic patients on peritoneal dialysis. Perit Dial Int 2003, 23:255-259.
40. Neil J.A., Knuckey C.J., Tanenberg R.J. Prevention of foot ulcers in patients with diabetes and end stage renal disease. Nephrol Nurs J 2003, 30:39-43.
41. Lavery L., Hunt N.A., Ndip A., et al. Impact of chronic kidney disease on survival after amputation in individuals with diabetes. Diabetes Care 2010, 33:2365-2368.
42. Venermo M. The role of chronic kidney disease as a predictor of outcome after revascularization of the ulcerated diabetic foot. Diabetologia 2011, 54:2971-2977.
43. O'Hare A.M. Impact of renal insufficiency on short-term morbidity and mortality after lower extremity revascularization: data from the Department of Veterans Affairs' National Surgical Quality Improvement Program. J Am Soc Nephrol 2003, 4:1287-1295.
44. Attinger D.C., Ducic I., Neville R.F., et al. The relative roles of aggressive wound care versus revascularization in salvage of the threatened lower extremity in the renal failure, diabetic patient. Plast Reconstruct Surg 2002, 109:1281-1290.
45. Fife C.E., Buyukcakir C., Otto G.H., et al. The predictive value of transcutaneous oxygen tension measurement in diabetic lower extremity ulcers treated with hyperbaric oxygen therapy: a retrospective analysis of 1144 patients. Wound Repair Regen 2002, 10:198-207.